Trials / Recruiting
RecruitingNCT05527652
Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University of Michigan · Academic / Other
- Sex
- All
- Age
- 3 Years – 21 Years
- Healthy volunteers
- Not accepted
Summary
The researchers are investigating if the Self-Supporting Nasopharyngeal Airway (ssNPA) device can be used in the treatment of obstructive sleep apnea in children with Hypotonic Upper Airway Obstruction (HUAO).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Self-Supporting Nasopharyngeal Airway (ssNPA) | The ssNPA device is made of a single piece of flexible, medical-grade silicone. It is inserted through one nostril and extends to the anatomic position bypassing the upper airway obstruction above the epiglottis. |
Timeline
- Start date
- 2022-11-16
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2022-09-02
- Last updated
- 2026-03-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05527652. Inclusion in this directory is not an endorsement.